As the economy recovers and healthcare demand continues to rise, Vietnam’s pharmaceutical industry is entering a period of robust growth. By 2026, the market value is forecasted to exceed USD 10 billion, positioning Vietnam as one of the most promising markets in Southeast Asia.
✅ 1. Surging Market Demand
A rapidly aging population and a growing prevalence of non-communicable diseases.
Increasing public awareness of healthcare and disease prevention.
Urbanization and rising per capita income → Boosting demand for pharmaceuticals and dietary supplements.
✅ 2. Strong Government Support
The government is accelerating its Pharmaceutical Industry Development Strategy to 2030, with a vision to 2045:
➤ Prioritizing the localization of raw materials and encouraging the production of high-quality generics.
➤ Expanding factories that meet EU-GMP and PIC/S-GMP standards.
➤ Simplifying drug registration procedures and promoting technology transfer.
✅ 3. Growing International Cooperation
Vietnam has become a key destination for major global pharmaceutical players such as Sanofi, AstraZeneca, GSK, and others.
The global shift of supply chains toward Southeast Asia is attracting substantial investment in local manufacturing and R&D.
⚠️ 1. High Dependency on Imported APIs
80–90% of pharmaceutical ingredients (APIs) are still sourced from China and India.
This dependence leaves domestic firms vulnerable to cost fluctuations, export policies, and global supply chain disruptions.
⚠️ 2. Fierce Competition
Intense competition from both local and international pharmaceutical companies.
Price pressure is particularly strong in the generic drug and commodity ingredient segments.
⚠️ 3. Limited R&D and Advanced Manufacturing Capacity
The pharmaceutical R&D ecosystem remains underdeveloped, with weak collaboration between enterprises, research institutes, and universities.
The number of facilities meeting high international standards (EU-GMP, US FDA) is still limited.
In this evolving landscape, SMEs can gain competitive advantage by:
Focusing on quality: Selecting internationally certified raw materials with transparent sourcing.
Building global partnerships: Diversifying supply sources and reducing supply chain risks.
Tapping into niche markets: Such as natural herbal extracts, dietary supplements, and ingredients for veterinary and personal care products.
✨ Conclusion
Vietnam’s pharmaceutical market is poised for rapid growth, offering significant opportunities. Yet, to fully capitalize on this potential and navigate ongoing challenges, companies must proactively enhance their capabilities, remain strategically agile, and invest in sustainable brand-building.
At H‑T Biotechpharma, we are committed to supporting our clients – from sourcing globally certified ingredients to co-developing impactful products – contributing to a high-quality, sustainable, and globally integrated pharmaceutical industry.
"Let’s grow together – from the very first step."
